Edition:
India

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

1.89USD
23 Apr 2018
Change (% chg)

$-0.03 (-1.56%)
Prev Close
$1.92
Open
$1.93
Day's High
$1.93
Day's Low
$1.89
Volume
726
Avg. Vol
2,766
52-wk High
$4.65
52-wk Low
$1.75

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans that includes the use of the Company's platform technologies that enables the creation of drug therapies primarily for orphan indications. The... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

BRIEF-Xenetic Biosciences qtrly ‍loss per share $0.26​

* Xenetic Biosciences Inc- ‍current cash position is about $8.0 million, sufficient to fund operations through Q2 of 2018​‍​ Source text for Eikon: [ID: nBw9dWFZHa] Further company coverage:

15 Nov 2017

BRIEF-Xenetic Biosciences enters into sublicense agreement with subsidiary of Shire Plc

* Xenetic Biosciences enters into sublicense agreement related to its Polyxen technology with Baxalta Inc., a wholly-owned subsidiary of Shire Plc

02 Nov 2017

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $68.14 -0.29

Earnings vs. Estimates